LAG-3 COMBINATION THERAPY FOR THE TREATMENT OF CANCER
Application
US20260078184A1
Kind: A1
Mar 19, 2026
Assignee
Bristol-Myers Squibb Company
Inventors
Shivani SRIVASTAVA
Abstract
The invention provides a method of treating a tumor in a human gastric cancer or gastroesophageal junction cancer patient.
CPC Classifications
C07K 16/2818
A61K 45/06
A61P 35/00
A61K 2039/505
A61K 2039/54
A61K 2039/545
Filing Date
2025-07-23
Application No.
19277809